COVID-19 Test Solution
Fast-track your Lab by leveraging BGI’s unprecedented ability to scale kit production

Fast and accurate diagnosis is critical as the number of patients infected with 2019-nCoV grows exponentially. Many labs are struggling to scale a diagnostic test for 2019-nCoV. Cambridge Genetics supplies the most widely used Real-Time PCR Test Kit for 2019-nCoV. BGI’s Real-Time Fluorescent RT-PCR kit is a qualitative in vitro nucleic acid amplification assay which detects 2019-nCoV using Reverse transcription PCR from throat swab and Bronchoalveolar Lavage Fluid (BALF) samples. Leverage BGI’s unprecedented ability scale and deliver test kits to your Lab within 5-7 business days of an order.

The most widely used 2019-nCoV test kits in the world

Compatible with numerous real-time PCR platforms, each kit includes an Internal Control and Positive Control. The BGI Real-Time PCR Kit for 2019-nCoV has the highest global kit production capacity currently available. Kits have been delivered to over 30 countries and regions including China, Japan, Singapore, South Korea, Israel, the Middle East, Europe and now the US. As of March 2020, BGI has completed the production of more than 1.5 million test kits. BGI’s Real-Time Fluorescent RT-PCR kit for detecting 2019-nCoV (SARS-CoV-2) has been awarded FDA approval and now is commercially available in the US. Contact us to learn how your lab can get started.